| USP-1544916 |
Polyvinyl Chloride, Plasticized (3 Strips, 2” x 2 1/2” each) |
9002-86-2 |
|
| 3904220000 |
|
|
|
| USP-1546285 |
Polydextrose (200 mg) |
68424-04-4 |
|
| 3913901000 |
|
|
|
| USP-1546423 |
Polyethylene Glycol 300 (1 g) |
25322-68-3 |
|
| 3907290000 |
|
|
|
| USP-1548349 |
Potassium Nitrate (100 mg) |
7757-79-1 |
UN1486 |
| USP-1570508 |
Propantheline Bromide (200 mg) |
50-34-0 |
|
| 2932992100 |
|
|
|
| USP-1572208 |
Propionic Acid (1.5 mL/ampule; 3 ampules) |
1979/9/4 |
UN3463 |
| USP-1592227 |
Quazepam Related Compound A (30 mg) (7-Chloro-1-(2,2,2 trifluoroethyl)-5-(2-Fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one) |
49606-44-2 |
|
| 2933998350 |
|
|
|
| USP-1601420 |
Residual Solvent Class 2 – 1,2-Dichloroethene (1.2 mL/ampule; 3 ampules) |
540-59-0 |
|
| 2903290000 |
|
|
|
| USP-1601500 |
Residual Solvent Class 2 – N,N-Dimethylformamide (1.2 mL/ampule; 3 ampules) |
N/A |
|
| 2924190002 |
|
|
|
| USP-1601725 |
Residual Solvent Class 2 – Nitromethane (1.2 mL/ampule; 3 ampules) |
75-52-5 |
|
| 2904206000 |
|
|
|
| USP-1611988 |
Senkyunolide A |
63038-10-8 |
|
| 2932206000 |
|
|
|
| USP-1613010 |
Desiccant, Small (2 pouches (approximate weight 44 grams, each)) |
1318-02-1 |
|
| 3824999370 |
|
|
|
| USP-1613032 |
Desiccant, Large (2 pouches (approximate weight 80 grams, each)) |
1318-02-1 |
|
| 3824999370 |
|
|
|
| USP-1614419 |
Sodium MonoFluorophosphate (100 mg) |
10163-15-2 |
|
| 2826909000 |
|
|
|
| USP-1614432 |
Sodium Nitrate (200 mg) |
7631-99-4 |
|
| 3102500000 |
|
|
|
| USP-1614589 |
Sodium Picosulfate Related Compound A (20 mg) (Sodium 4-((4-hydroxyphenyl)(pyridin-2-yl)methyl)phenyl sulfate) |
32500-19-9 |
|
| 2933399095 |
|
|
|
| USP-1643260 |
Tamsulosin Hydrochloride (200 mg) |
106463-17-6 |
|
| 2935904000 |
|
|
|
| USP-1643510 |
Terbutaline Related Compound A (50 mg) (2-(tert-Butylamino)-1-(3,5-dihydroxyphenyl)ethan-1-one sulfate) |
N/A |
|
| 2922504500 |
|
|
|
| USP-1670502 |
Tolmetin Sodium (500 mg) |
64490-92-2 |
|
| 2933995500 |
|
|
|
| USP-1671479 |
Tolterodine System Suitability Mixture (15 mg) |
NA |
|
| 2922299000 |
|
|
|
| USP-1681611 |
Triclabendazole (25 mg) |
68786-66-3 |
|
| 2933994600 |
|
|
|
| USP-1708004 |
Valganciclovir Hydrochloride (500 mg) |
175865-59-5 |
|
| 2933595960 |
|
|
|
| USP-1711455 |
Verbascoside (15 mg) (2-(3,4-Dihydroxyphenyl)ethyl 3-O-(6-deoxy-alpha-L-mannopyranosyl)-4-O-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-Beta-D-glucopyranoside) |
61276-17-3 |
|
| 2938900000 |
|
|
|
| USP-1714007 |
Vincristine Sulfate (50 mg) |
2068-78-2 |
UN1544 |
| USP-1716002 |
Retinyl Acetate (Vitamin A) (10 ampules x 0.5 g) |
127-47-9 |
|
| 2936210000 |
|
|
|
| USP-1724420 |
Ziprasidone Related Compound B (10 mg) (5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione) |
1159977-56-6 |
|
| 2934200000 |
|
|
|
| USP-1724805 |
Zolazepam Hydrochloride (500 mg) |
33754-49-3 |
|
| 2933996500 |
|
|
|
| USP-1733122 |
Aztec Marigold Zeaxanthin Extract (4 x 50 mg) |
148-68-3 |
|
| 1302190200 |
|
|
|
| USP-1A00040 |
Hydroxythiadiazol Sulfoxide Derivative (25 mg) (4-morpholino-1,2,5-thiadiazol-3(2H)-one 1-oxide) |
75202-36-7 |
|
| 2934990005 |
|
|
|
| USP-1A01440 |
Ticlopidine Pyridinium Analog (25 mg) (5-(2-chlorobenzyl)thieno[3,2-c]pyridin-5-ium, chloride) |
53885-64-6 |
|
| 2934990005 |
|
|
|
| USP-1A01550 |
Rivaroxaban Open Ring S-isomer (25 mg) ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide) |
1325210-62-5 |
|
| 2934990005 |
|
|
|
| USP-1065480 |
Beta Carotene (7 x 100 mg) (需冷链运输) |
7235-40-7 |
|
| 3204196100 |
|
|
|
| USP-1078766 |
Bupropion Hydrochloride Related Compound C (40 mg) (1-(3-chlorophenyl)-2-hydroxypropan-1-one) (需冷链运输) |
N/A |
|
| 2914404000 |
|
|
|
| USP-1078799 |
Bupropion Hydrochloride Related Compound F (40 mg) (1-(3-chlorophenyl)-1-hydroxypropan-2-one) (需冷链运输) |
857233-13-7 |
|
| 2914404000 |
|
|
|
| USP-1270468 |
Filgrastim for Bioassay (96,815 IU) (需冷链运输) |
121181-53-1 |
|
| 3002130000 |
|
|
|
| USP-1270537 |
Filgrastim System Suitability (需冷链运输) (1 mg) |
121181-53-1 |
|
| 3002140000 |
|
|
|
| USP-1282707 |
Fondaparinux Sodium for Assay (0.6 mL) (需冷链运输) |
114870-03-0 |
|
| 2932999000 |
|
|
|
| USP-1304016 |
Heparin Sodium for Assays (9.5 mg) (需冷链运输) |
9041/8/1 |
|
| 3001900190 |
|
|
|
| USP-1342059 |
Insulin Glargine (15.27 mg) (需冷链运输) |
160337-95-1 |
|
| 2937190000 |
|
|
|
| USP-1342060 |
Insulin Glargine for Peak Identification (3.2 mg) (Mixture of Insulin Glargine and 0A-Arg-Insulin Glargine) (需冷链运输) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1342150 |
High Molecular Weight Insulin Human (8.4 mg) (需冷链运输) |
11061-68-0 |
|
| 2937120000 |
|
|
|
| USP-1365043 |
Levothyroxine Peak Identification Mixture (3 x 5 mL) (1 mg/mL) (需冷链运输) |
N/A |
UN1230 |
| USP-1430349 |
Methyl Linolenate (5 x 50 mg) (需冷链运输) |
301-00-8 |
|
| 2916151000 |
|
|
|
| USP-1445550 |
Monoclonal IgG System Suitability (2 mg) (需冷链运输) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1499414 |
Paricalcitol Solution (3 mL) (需冷链运输) |
N/A |
UN1170 |
| USP-1500626 |
Pegfilgrastim for Bioassay (需冷链运输) |
208265-92-3 |
|
| 3002140000 |
|
|
|
| USP-1526030 |
Phenoxybenzamine Nitrile (50 mg) (需冷链运输) (3-[Benzyl(1-phenoxypropan-2-yl)amino]propanenitrile) |
N/A |
|
| 2926900005 |
|
|
|
| USP-1548098 |
Pomegranate Juice Concentrate (5 x 1 mL) |
N/A |
|
| 2009899100 |
|
|
|
| USP-1180026 |
Dextroamphetamine Related Compound B CII (25 mg) (Phenyl acetone) |
103-79-7 |
|
| 2914310000 |
|
|
|
| USP-1258305 |
Ethchlorvynol CIV (0.7 mL) |
113-18-8 |
UN2810 |
| USP-1359506 |
Levmetamfetamine CII (75 mg) |
33817-09-3 |
|
| 2921490002 |
|
|
|
| USP-1496959 |
Paraldehyde CIV (3 x 1.5 mL) |
123-63-7 |
|
| 2912505000 |
|
|
|
| USP-1342401 |
Interferon Beta-1A (1.0 mL) (国际冷链运输要求) |
145258-61-3 |
|
| 3002130000 |
|
|
|
| USP-1445539 |
USP mAb 001, Monoclonal IgG1 (国际冷链运输要求) |
174722-31-7 |
|
| 3002130000 |
|
|
|
| USP-1445547 |
USP mAb 002, Monoclonal IgG1 (国际冷链运输要求) |
216974-75-3 |
|
| 3002130000 |
|
|
|
| USP-1445595 |
USP mAb 003, Monoclonal IgG1 (国际冷链运输要求) |
912628-39-8 |
|
| 3002130000 |
|
|
|
| USP-1667643 |
Tigecycline (300 mg) (国际冷链运输要求) |
220620-09-7 |
UN3077 |
| USP-1211200 |
Dimethylamine Solution (6 x 3 mL) (International Restricted Sales Item) |
124-40-3 (Dimethylamine) |
UN1160 |
| USP-1050905 |
Benzaldehyde (3 X 1 mL) (List Chemical) |
100-52-7 |
UN1990 |
| USP-1082592 |
Butyl Anthranilate (1 mL) (List Chemical) |
7756-96-9 |
|
| 2922493800 |
|
|
|
| USP-1381742 |
Meradimate (500 mg/ampule) (Menthyl Anthranilate) (List Chemical) |
134-09-8 |
|
| 2922493800 |
|
|
|
| USP-1607299 |
Safrole (4 x 50 mg) (List Chemical) (5-allylbenzo-1,3-dioxole) |
94-59-7 |
UN3082 |
| USP-1002811 |
Acetaldehyde (3 x 1.1 mL) |
75-07-0 |
UN1089 |
| USP-1005706 |
Glacial Acetic Acid (3 x 1.5 mL ampules) |
64-19-7 |
UN2789 |
| USP-1006801 |
Acetone (1.5 mL/ampule; 3 ampules) |
67-64-1 |
UN1090 |
| USP-1009479 |
2-Acetylpyridine (1 g) |
1122-62-9 |
|
| 2933399095 |
|
|
|
| USP-1009901 |
Acetyltributyl Citrate (3 x 200 mg) |
77-90-7 |
UN3082 |
| USP-1009923 |
Acetyltriethyl Citrate (100 mg) |
77-89-4 |
|
| 2918150000 |
|
|
|
| USP-1012688 |
Alcohol Determination – Alcohol (5 mL/ampule; 5 ampules) |
64-17-5 |
|
| 2208909002 |
|
|
|
| USP-1012768 |
Alcohol (1.2 mL/ampule; 5 ampules) |
64-17-5 |
UN1170 |
| USP-1012772 |
Dehydrated Alcohol (1.2 mL/ampule; 5 ampules) |
64-17-5 |
UN1170 |
| USP-1013206 |
Almond Oil (1 g) |
8007-69-0 |
|
| 1515908100 |
|
|
|
| USP-1598020 |
Rabeprazole Related Compound A (25 mg) (1-(1H-Benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate, sodium salt) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1598031 |
Rabeprazole Related Compound B (15 mg) (2-{[(1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) |
924663-38-7 |
|
| 2933997500 |
|
|
|
| USP-1598042 |
Rabeprazole Related Compound C (25 mg) (1H-Benzimidazole-2-thiol) |
583-39-1 |
UN2811 |
| USP-1598053 |
Rabeprazole Related Compound D (25 mg) (2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfonyl]benzimidazole) |
117976-47-3 |
|
| 2933998350 |
|
|
|
| USP-1598064 |
Rabeprazole Related Compound E (25 mg) (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole) |
117977-21-6 |
|
| 2933998350 |
|
|
|
| USP-1598075 |
Rabeprazole Related Compound F (15 mg) (2-{[(4-Chloro-3-methyl-2-pyridyl)methyl]sulfinyl}benzimidazole) |
168167-42-8 |
|
| 2933997500 |
|
|
|
| USP-1598097 |
Racepinephrine Hydrochloride (30 mg) |
329-63-5 |
UN2811 |
| USP-1598100 |
Ractopamine Hydrochloride (200 mg) |
90274-24-1 |
|
| 2922504500 |
|
|
|
| USP-1598201 |
Raloxifene Hydrochloride (200 mg) |
82640-04-8 |
UN3077 |
| USP-1598234 |
Raloxifene Related Compound C (20 mg) (1-(2-{4-[6-hydroxy-2-(4-hydroxyphenyl)benzothiophene-3-carbonyl]phenoxy}ethyl)piperidine 1-oxide monohydrate) |
195454-31-0 |
|
| 2934990002 |
|
|
|
| USP-1598267 |
Raltegravir Related Compound E (20 mg) (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide) |
1193687-87-4 |
|
| 2934990005 |
|
|
|
| USP-1598278 |
Raltegravir Potassium (200 mg) |
871038-72-1 |
|
| 2934990005 |
|
|
|
| USP-1598303 |
Ramipril (125 mg) |
87333-19-5 |
|
| 2933995300 |
|
|
|
| USP-1598314 |
Ramipril Related Compound A (30 mg) ((2S,3aS,6aS)-1-[(S)2-[[(S)-1-(Methoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid) |
108313-11-7 |
|
| 2933998350 |
|
|
|
| USP-1598323 |
Ramipril Related Compound B (20 mg) (Ramipril Isopropylester) |
295328-72-2 |
|
| 2933997500 |
|
|
|
| USP-1598338 |
Ramipril Related Compound C (20 mg) (Hexahydroramipril Hydrochloride) |
N/A |
|
| 2933999552 |
|
|
|
| USP-1598347 |
Ramipril Related Compound D (20 mg) (Ramipril Diketopiperazine) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1598405 |
Ranitidine Hydrochloride (200 mg) |
66357-59-3 |
|
| 2932190002 |
|
|
|
| USP-1598450 |
Ranitidine Resolution Mixture (20 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1598507 |
Ranitidine Related Compound A (50 mg) (5-[[(2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine, hemifumarate salt) |
91224-69-0 |
|
| 2932190002 |
|
|
|
| USP-1598609 |
Ranitidine Related Compound B (50 mg) (N,N’-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine) |
72126-78-4 |
|
| 2932190002 |
|
|
|
| USP-1598700 |
Ranitidine Related Compound C (50 mg) (N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]sulfinyl]ethyl]-N-methyl-2-nitro-1,1-ethenediamine) |
73851-70-4 |
|
| 2932190002 |
|
|
|
| USP-1598733 |
p-Ranolazine (25 mg) (N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(4-methoxyphenoxy)propyl]piperazin-1-yl}acetamide) |
1393717-45-7 |
|
| 2933595960 |
|
|
|
| USP-1598744 |
Ranolazine (100 mg) |
95635-55-5 |
UN2811 |
| USP-1598755 |
Ranolazine Related Compound A (50 mg) ((+/-)-2-[(2-methoxyphenoxy)methyl]oxirane) |
2210-74-4 |
|
| 2918992090 |
|
|
|
| USP-1598766 |
Ranolazine Related Compound B (50 mg) (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1598777 |
Ranolazine Related Compound C (50 mg) (N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide) |
5294-61-1 |
|
| 2934990005 |
|
|
|
| USP-1598788 |
Ranolazine Related Compound D (50 mg) (2,2′-(Piperazine-1,4-diyl)bis[N-(2,6-dimethylphenyl)acetamide]) |
380204-72-8 |
|
| 2934990005 |
|
|
|
| USP-1598802 |
Raspberry Alcohol (50 mg) (4-(3-Hydroxybutyl)phenol) |
69617-84-1 |
|
| 2907290500 |
|
|
|
| USP-1598813 |
Raspberry Ketone (100 mg) (4-(4-Hydroxyphenyl)butan-2-one) |
5471-51-2 |
|
| 2914500000 |
|
|
|
| USP-1599000 |
Rauwolfia Serpentina (15 g) |
8063-17-0 |
UN1544 |
| USP-1599500 |
Powdered Red Clover Extract (500 mg) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1600121 |
Rebaudioside A (500 mg) (13-[(2-O-Beta-D-glucopyranosyl-3-O-Beta-D-glucopyranosyl-Beta-D-glucopyranosyl)oxy] kaur-16-en-18-oic acid Beta-D-glucopyranosyl ester) |
58543-16-1 |
|
| 2938900000 |
|
|
|
| USP-1600201 |
Regorafenib (200 mg) |
1019206-88-2 |
|
| 2933399095 |
|
|
|
| USP-1600212 |
Regorafenib Related Compound A (15 mg) (4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide) |
757251-39-1 |
|
| 2933399095 |
|
|
|
| USP-1600303 |
Refined Bleached Shellac (1 g) |
9000-59-3 |
|
| 1301900190 |
|
|
|
| USP-1600314 |
Regular Bleached Shellac (100 mg) |
9000-59-3 |
|
| 1301900190 |
|
|
|
| USP-1600813 |
Repaglinide (200 mg) |
135062-02-1 |
|
| 2933399095 |
|
|
|
| USP-1600824 |
Repaglinide Related Compound A (10 mg) ((S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butylamine, N-acetyl-L-glutamate salt) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1600835 |
Repaglinide Related Compound B (50 mg) (3-Ethoxy-4-ethoxycarbonylphenylacetic acid) |
99469-99-5 |
|
| 2918992090 |
|
|
|
| USP-1600846 |
Repaglinide Related Compound C (25 mg) ((S)-2-Ethoxy-4-[2-[[2-phenyl-1-[2-(1-piperidinyl)phenyl]ethyl]amino]-2-oxoethyl] benzoic acid) |
1803084-79-8 |
UN2811 |
| USP-1600868 |
Repaglinide Related Compound E (20 mg) ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid) |
147852-26-4 |
|
| 2933399095 |
|
|
|
| USP-1601000 |
Reserpine (200 mg) |
50-55-5 |
|
| 2939800000 |
|
|
|
| USP-1602003 |
Resorcinol (200 mg) |
108-46-3 |
UN2876 |
| USP-1602105 |
trans-Resveratrol (100 mg) |
501-36-0 |
|
| 2907299000 |
|
|
|
| USP-1602580 |
Rhodiola Rosea Root and Rhizome Dry Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1602599 |
Rhoifolin (15 mg) |
17306-46-6 |
|
| 2938900000 |
|
|
|
| USP-1602706 |
Ribavirin (200 mg) |
36791-04-5 |
|
| 2934990005 |
|
|
|
| USP-1602717 |
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
39925-19-4 |
|
| 2933999552 |
|
|
|
| USP-1602740 |
Ribavirin Related Compound D (15 mg) (1H-1,2,4-triazole-3-carboxamide) |
3641/8/5 |
|
| 2933999552 |
|
|
|
| USP-1603006 |
Riboflavin (500 mg) |
83-88-5 |
|
| 2936230000 |
|
|
|
